Tengjun Biotechnology Corp. Accumulated Other Comprehensive Income
Tengjun Biotechnology Corp. had Accumulated Other Comprehensive Income of -$2.30 million as of 2023-06-30, per its 10-Q filed 2023-08-15.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2023-08-15
- 2023-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$2.30M.
- 2023-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$298.80K.
- 2022-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$420.38K.
- 2022-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$650.63K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax | Accumulated Other Comprehensive Income (Loss), Net of Tax as first filed |
|---|---|---|
| 2023-06-30 | -$2.30M 10-Q · filed 2023-08-15 | |
| 2023-03-31 | -$298.80K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | -$420.38K 10-Q · filed 2023-08-15 | |
| 2022-09-30 | -$650.63K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | -$221.65K 10-Q/A · filed 2022-09-16 | $13.13K 10-Q · filed 2022-08-15 |
| 2022-03-31 | -$177.50K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | -$168.53K 10-K · filed 2023-04-17 | |
| 2020-12-31 | -$141.21K 10-K · filed 2022-03-31 |